Ducentis is an England-based biotechnology company that develops and commercializes novel therapies for the treatment of inflammation and autoimmune diseases.
Business Model:
Revenue: $4.5M
Employees: 2-10
Ducentis was acquired by
Arcutis Biotherapeutics.
The acquisition happend on 2022-09-08.
Details of the transaction were not public
Address: 264 Banbury Road
City: Oxfordshire
State: england
Zip: OX2 7DY
Country: GB
Ducentis is an England-based biotechnology company that develops and commercializes novel therapies for the treatment of inflammation and autoimmune diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2015 | Seed Round | 1 | $121.3k |
Oxford Technology Management Oxford Technology Management |
8/2017 | Angel Round | 2 | $1.1M |
Capital Cell Oxford Technology Management Capital Cell Oxford Technology Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|